Luxi Research Development vs Selling General Administrative Analysis

000830 Stock

11.53 0.13 1.14%

Luxi Chemical financial indicator trend analysis is infinitely more than just investigating Luxi Chemical Group recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Luxi Chemical Group is a good investment. Please check the relationship between Luxi Chemical Research Development and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Luxi Chemical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Luxi Chemical Group Research Development account and Selling General Administrative. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Luxi Chemical's Research Development and Selling General Administrative is -0.58. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Luxi Chemical Group, assuming nothing else is changed. The correlation between historical values of Luxi Chemical's Research Development and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Luxi Chemical Group are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Research Development i.e., Luxi Chemical's Research Development and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.58

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Research Development

Selling General Administrative

Most indicators from Luxi Chemical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Luxi Chemical Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Luxi Chemical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of November 30, 2024, Selling General Administrative is expected to decline to about 82.5 M. In addition to that, Tax Provision is expected to decline to about 221.6 M

	2021	2022	2023	2024 (projected)
Operating Income	8.0B	4.3B	1.8B	1.4B
Total Revenue	31.8B	30.4B	25.4B	26.6B

Operating Income Total Revenue

Luxi Chemical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Other Liab	Short Term Investments	Intangible Assets	Net Tangible Assets	Other Stockholder Equity	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.56	0.87	0.79	0.75	0.11	-0.08	0.59	0.58	0.09	0.63	0.46	0.93	0.87	0.82	0.65	0.72	0.78	0.72	-0.6	0.43	0.7	-0.3	0.83	0.69	0.27
Other Current Liab	0.56		0.5	0.35	0.47	-0.23	-0.26	0.22	0.32	0.61	0.27	0.35	0.54	0.32	0.32	0.42	0.26	0.34	0.3	-0.49	-0.21	0.4	0.18	0.49	0.36	0.25
Total Current Liabilities	0.87	0.5		0.51	0.45	0.37	0.19	0.28	0.34	0.26	0.53	0.61	0.98	0.68	0.7	0.39	0.72	0.58	0.35	-0.32	0.36	0.71	-0.08	0.65	0.4	0.24
Total Stockholder Equity	0.79	0.35	0.51		0.97	-0.16	-0.3	0.92	0.47	-0.1	0.45	0.07	0.6	0.69	0.94	0.89	0.43	0.95	0.9	-0.82	0.66	0.68	-0.6	0.85	0.93	0.24
Retained Earnings	0.75	0.47	0.45	0.97		-0.33	-0.46	0.89	0.43	0.04	0.32	-0.04	0.54	0.61	0.87	0.9	0.32	0.92	0.92	-0.91	0.55	0.66	-0.63	0.86	0.95	0.21
Accounts Payable	0.11	-0.23	0.37	-0.16	-0.33		0.77	-0.26	0.15	-0.18	0.39	0.54	0.34	0.23	0.06	-0.33	0.53	-0.17	-0.33	0.56	0.08	-0.11	0.18	-0.21	-0.34	-0.3
Cash	-0.08	-0.26	0.19	-0.3	-0.46	0.77		-0.44	0.16	-0.12	0.28	0.52	0.17	0.06	-0.09	-0.47	0.44	-0.32	-0.54	0.58	-0.1	-0.17	0.31	-0.33	-0.53	-0.26
Other Assets	0.59	0.22	0.28	0.92	0.89	-0.26	-0.44		0.44	-0.07	0.29	-0.19	0.38	0.54	0.83	0.93	0.23	0.88	0.89	-0.8	0.72	0.57	-0.6	0.73	0.93	0.12
Long Term Debt	0.58	0.32	0.34	0.47	0.43	0.15	0.16	0.44		0.02	0.7	0.25	0.53	0.74	0.47	0.42	0.73	0.34	0.4	-0.35	0.09	0.1	-0.21	0.3	0.32	-0.12
Net Receivables	0.09	0.61	0.26	-0.1	0.04	-0.18	-0.12	-0.07	0.02		-0.21	0.03	0.22	-0.16	0.0	0.09	-0.04	-0.01	-0.13	-0.17	-0.16	0.21	0.31	0.12	-0.03	-0.14
Inventory	0.63	0.27	0.53	0.45	0.32	0.39	0.28	0.29	0.7	-0.21		0.48	0.64	0.86	0.48	0.36	0.88	0.3	0.33	-0.16	0.1	0.17	0.09	0.28	0.24	0.31
Other Current Assets	0.46	0.35	0.61	0.07	-0.04	0.54	0.52	-0.19	0.25	0.03	0.48		0.6	0.32	0.17	-0.19	0.49	0.13	-0.14	0.3	-0.13	0.19	0.36	0.19	-0.19	0.07
Total Liab	0.93	0.54	0.98	0.6	0.54	0.34	0.17	0.38	0.53	0.22	0.64	0.6		0.79	0.75	0.48	0.8	0.63	0.45	-0.39	0.37	0.69	-0.13	0.69	0.47	0.22
Common Stock	0.87	0.32	0.68	0.69	0.61	0.23	0.06	0.54	0.74	-0.16	0.86	0.32	0.79		0.7	0.58	0.88	0.58	0.66	-0.48	0.35	0.43	-0.27	0.58	0.58	0.28
Property Plant Equipment	0.82	0.32	0.7	0.94	0.87	0.06	-0.09	0.83	0.47	0.0	0.48	0.17	0.75	0.7		0.84	0.57	0.93	0.76	-0.73	0.73	0.78	-0.55	0.83	0.84	0.19
Other Liab	0.65	0.42	0.39	0.89	0.9	-0.33	-0.47	0.93	0.42	0.09	0.36	-0.19	0.48	0.58	0.84		0.29	0.83	0.85	-0.89	0.61	0.66	-0.45	0.78	0.92	0.32
Short Term Investments	0.72	0.26	0.72	0.43	0.32	0.53	0.44	0.23	0.73	-0.04	0.88	0.49	0.8	0.88	0.57	0.29		0.33	0.27	-0.18	0.19	0.3	-0.1	0.33	0.24	0.08
Intangible Assets	0.78	0.34	0.58	0.95	0.92	-0.17	-0.32	0.88	0.34	-0.01	0.3	0.13	0.63	0.58	0.93	0.83	0.33		0.85	-0.78	0.71	0.77	-0.57	0.88	0.91	0.25
Net Tangible Assets	0.72	0.3	0.35	0.9	0.92	-0.33	-0.54	0.89	0.4	-0.13	0.33	-0.14	0.45	0.66	0.76	0.85	0.27	0.85		-0.82	0.61	0.58	-0.6	0.82	0.95	0.22
Other Stockholder Equity	-0.6	-0.49	-0.32	-0.82	-0.91	0.56	0.58	-0.8	-0.35	-0.17	-0.16	0.3	-0.39	-0.48	-0.73	-0.89	-0.18	-0.78	-0.82		-0.41	-0.61	0.57	-0.74	-0.9	-0.33
Long Term Investments	0.43	-0.21	0.36	0.66	0.55	0.08	-0.1	0.72	0.09	-0.16	0.1	-0.13	0.37	0.35	0.73	0.61	0.19	0.71	0.61	-0.41		0.71	-0.54	0.66	0.68	-0.02
Short Long Term Debt	0.7	0.4	0.71	0.68	0.66	-0.11	-0.17	0.57	0.1	0.21	0.17	0.19	0.69	0.43	0.78	0.66	0.3	0.77	0.58	-0.61	0.71		-0.27	0.91	0.69	0.35
Total Current Assets	-0.3	0.18	-0.08	-0.6	-0.63	0.18	0.31	-0.6	-0.21	0.31	0.09	0.36	-0.13	-0.27	-0.55	-0.45	-0.1	-0.57	-0.6	0.57	-0.54	-0.27		-0.4	-0.64	0.28
Short Term Debt	0.83	0.49	0.65	0.85	0.86	-0.21	-0.33	0.73	0.3	0.12	0.28	0.19	0.69	0.58	0.83	0.78	0.33	0.88	0.82	-0.74	0.66	0.91	-0.4		0.84	0.28
Non Current Assets Total	0.69	0.36	0.4	0.93	0.95	-0.34	-0.53	0.93	0.32	-0.03	0.24	-0.19	0.47	0.58	0.84	0.92	0.24	0.91	0.95	-0.9	0.68	0.69	-0.64	0.84		0.23
Non Currrent Assets Other	0.27	0.25	0.24	0.24	0.21	-0.3	-0.26	0.12	-0.12	-0.14	0.31	0.07	0.22	0.28	0.19	0.32	0.08	0.25	0.22	-0.33	-0.02	0.35	0.28	0.28	0.23

Click cells to compare fundamentals

Luxi Chemical Account Relationship Matchups

Luxi Chemical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.2B	31.9B	32.1B	34.4B	35.3B	17.7B
Other Current Liab	4.2B	2.3B	1.8B	3.4B	66.8M	63.5M
Total Current Liabilities	15.0B	14.0B	9.1B	12.0B	13.9B	7.8B
Total Stockholder Equity	11.2B	14.3B	17.9B	17.3B	16.9B	17.7B
Retained Earnings	7.5B	7.6B	11.2B	10.5B	9.1B	9.6B
Accounts Payable	1.2B	956.1M	939.4M	1.6B	1.7B	1.5B
Cash	519.2M	363.9M	378.7M	294.9M	393.8M	542.9M
Other Assets	1.4B	1.5B	2.5B	2.7B	3.1B	3.3B
Long Term Debt	3.0B	2.1B	3.8B	3.7B	3.3B	2.3B
Net Receivables	1.2B	57.3M	110.1M	61.9M	34.8M	33.1M
Inventory	1.3B	1.9B	1.8B	1.7B	1.6B	1.2B
Other Current Assets	551.4M	636.2M	556.4M	742.6M	179.4M	170.5M
Total Liab	18.9B	17.5B	14.0B	17.0B	18.3B	10.6B
Property Plant Equipment	24.2B	24.7B	24.8B	26.5B	30.5B	32.0B
Other Liab	1.2B	1.2B	1.2B	1.2B	1.4B	1.5B
Intangible Assets	1.4B	1.9B	2.0B	2.3B	2.3B	2.4B
Net Tangible Assets	9.8B	12.3B	16.0B	15.0B	17.3B	11.8B
Other Stockholder Equity	1.5M	18.7M	35.4M	46.0M	41.4M	39.3M
Short Long Term Debt	8.4B	8.3B	3.4B	5.0B	8.3B	6.6B
Total Current Assets	3.6B	3.7B	2.8B	2.8B	2.5B	2.5B
Non Current Assets Total	27.1B	28.2B	29.3B	31.6B	32.8B	30.3B
Non Currrent Assets Other	379.8M	25.2B	1.3B	1.5B	1.3B	1.2B
Non Current Liabilities Total	4.5B	3.5B	4.9B	5.0B	4.4B	4.3B
Non Current Liabilities Other	955M	2.3B	3.0B	1.3M	1.1M	1.1M
Net Debt	10.9B	10.0B	6.8B	8.4B	11.1B	9.8B
Net Invested Capital	22.6B	24.6B	25.1B	26.1B	28.4B	25.8B
Net Working Capital	(11.3B)	(10.3B)	(6.3B)	(9.2B)	(11.4B)	(12.0B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Luxi Stock

Balance Sheet is a snapshot of the financial position of Luxi Chemical Group at a specified time, usually calculated after every quarter, six months, or one year. Luxi Chemical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Luxi Chemical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Luxi currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Luxi Research Development vs Selling General Administrative Analysis

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Research Development

Selling General Administrative

Luxi Chemical fundamental ratios Correlations

Luxi Chemical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Luxi Chemical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Luxi Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.98	Total Current Liabilities
Retained Earnings	+ 0.97	Total Stockholder Equity
Intangible Assets	+ 0.95	Total Stockholder Equity
Non Current Assets Total	+ 0.95	Retained Earnings
Non Current Assets Total	+ 0.95	Net Tangible Assets
Property Plant Equipment	+ 0.94	Total Stockholder Equity

Other Stockholder Equity	- 0.91	Retained Earnings
Non Current Assets Total	- 0.9	Other Stockholder Equity
Other Stockholder Equity	- 0.89	Other Liab
Other Stockholder Equity	- 0.82	Net Tangible Assets
Other Stockholder Equity	- 0.82	Total Stockholder Equity
Other Stockholder Equity	- 0.8	Other Assets